Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Share News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 380.00
Bid: 374.00
Ask: 386.00
Change: 0.00 (0.00%)
Spread: 12.00 (3.209%)
Open: 380.00
High: 380.00
Low: 380.00
Prev. Close: 380.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Danakali Hires Potash Mining Vet As COO

Tue, 13th Oct 2020 14:06

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

----------

Danakali Ltd - developing Colluli sulphate of potash project in Eritrea - Hires Rod McEachern as chief operating officer, starting December 3. McEachern was a senior executive at Nutrien and PotashCorp and brings experience in managing potash mines and processing plants. Says appointment comes at significant time, as Colluli moves toward phase 3 development. Separately says it proposes to issue 250,000 unlisted options to "a new employee of the company".

----------

Randall & Quilter Investment Holdings Ltd - Bermuda-based firm focused on non-life legacy insurance and program management - Adds Chief Financial Officer Thomas Solomon to board from November 2. Solomon had joined R&Q back in August from Bank of America. Separately says Florida-based subsidiary Accredited Surety & Casualty Co Inc has entered a new program partnership with Attune Insurance. Accredited will be an issuing carrier on behalf of Attune for a program that will provide property, general liability, crime, and equipment breakdown coverage to business owners in commercial properties.

----------

MaxCyte Inc - Gaithersburg, Maryland-based cell-based therapies and life sciences - Promotes Brad Calvin to chief commercial officer from executive vice president for Global Commercial Operations. Hires Sarah Haecker Meeks as vice president for Business Development and Steve Nardi as vice president for Manufacturing & Engineering Operations. Meeks was VP of Business Development at Synpromics, now part of AskBio. Nardi was VP of Worldwide Manufacturing at Iradimed Corp.

----------

Universe Group PLC - Southampton, Hampshire-based retail management solutions, payment and loyalty systems - Hires Carmel Warren as interim chief financial officer for an initial period of six months. Universe Group had announced last month that Finance Director Daryl Paton was stepping down "to pursue a new career opportunity" after three years in post. Paton will remain with the company until November 1 for a handover. Carmel was most recently CFO at AIM-listed D4T4 Solutions PLC and also worked at Exxon Mobil Corp. Continuing to look for a permanent CFO.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 May 2019 15:58

MaxCyte begins dosing second cohort in MCY-M11 clinical trial

(Sharecast News) - Clinical-stage, cell-based therapies and life sciences company MaxCyte has initiated dosing for the second cohort of patients in its US phase 1 clinical trial with MCY-M11 - the lead, wholly-owned, non-viral mRNA-based cell therapy candidate from its CARMA platform - it announced on Wednesday.

Read more
8 May 2019 12:11

MaxCyte Dosing Second Patients Group In Phase One Cancer Drug Trial

LONDON (Alliance News) - MaxCyte Inc on Wednesday said it has begun dosing for the second cohort of patients in its phase one trial of cancer drug MCY-M11.Shares in MaxCyte were down 5.7% a

Read more
24 Apr 2019 11:37

MaxCyte Outlook Confident As Loss Narrows In 2018 On Higher Revenue

LONDON (Alliance News) - MaxCyte Inc on Wednesday said its loss narrowed in 2018 on higher annual fees from its partners as it progresses on MCY-M11 therapeutic candidate development.The a

Read more
17 Apr 2019 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 18 April UnileverQ1 ResultsPZ CussonsTrading SolutionsTrading 19 events

Read more
8 Apr 2019 13:58

MaxCyte Launches ExPERT Cellular Engineering Technology Platform

LONDON (Alliance News) - MaxCyte Inc on Monday announced the launch of its new ExPERT technology platform for use in cellular engineering.MaxCyte also noted that its business had produced

Read more
8 Apr 2019 08:34

MaxCyte launches new generation of cellular engineering instruments

(Sharecast News) - MaxCyte on Monday launched its ExPERT technology platform, a family of instruments that are the next generation of its complex cellular engineering technology.

Read more
1 Mar 2019 10:05

MaxCyte Inks Multi-Drug Clinical And Commercial Agreement With Kite

LONDON (Alliance News) - Biotechnology company MaxCyte Inc on Friday said it has expanded its business relationship with Kite by signing a multi-drug clinical and commercial agreement.Under

Read more
5 Feb 2019 17:45

UPDATE: MaxCyte Placing Fully Subscribed; Raises Over GBP10.0 Million (ALLISS)

LONDON (Alliance News) - MaxCyte Inc on Tuesday said it has raised GBP10.0 million from a placing of 5.9 million shares at 170 pence each.The life sciences company placed 5.9 million just

Read more
5 Feb 2019 10:22

MaxCyte To Raise At Least GBP10 Million For Future Growth Plans (ALLISS)

LONDON (Alliance News) - MaxCyte Inc on Tuesday said it plans to raise at least GBP10 million via a placing of shares in order to accelerate its growth strategy.The life sciences company no

Read more
15 Jan 2019 11:18

MaxCyte Guides For Revenue Growth And Earnings Above Expectations

LONDON (Alliance News) - MaxCyte Inc on Tuesday guided for a 19% increase in its 2018 revenue with the firm expecting its annual earnings to exceed market views.The life science company in

Read more
24 Oct 2018 16:07

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 25 OctoberGreen & Smart WoodsAlumasc GroupFriday 26 OctoberArgos Capital

Read more
10 Oct 2018 11:47

MaxCyte Begins Patient Trial Of Proposed Cancer Treatment MCY-M11

LONDON (Alliance News) - Life sciences and medicines company MaxCyte Inc on Wednesday said it has dosed the first patient in its phase I trial for MCY-M11.MCY-M11 is a mesothelin targeting

Read more
24 Sep 2018 10:18

MaxCyte Interim Revenue Rises But Loss Widens On CARMA Development

LONDON (Alliance News) - MaxCyte Inc on Monday said its loss widened in the first half of 2018 as it continued to invest in the development of its CARMA drug platform.The life sciences said

Read more
17 Sep 2018 16:09

UK Earnings, Trading Statements Calendar - Next 7 Days

Tuesday 18 September Ocado GroupTrading Statement DP PolandHalf Year Year Year Year

Read more
26 Jul 2018 17:50

DIRECTOR DEALINGS: Wife Of MaxCyte Non-Executive Director Buys Shares

LONDON (Alliance News) - Medical & technology company MaxCyte Inc said that Karin Johnston, wife of Non-Executive Director John Johnston, purchased 11,500 shares at a price of 240 pence per on

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.